- Home
- CLNN vs WEA Comparison
CLNN vs WEA Comparison
Compare CLNN & WEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLNN | WEA |
|---|---|---|
| Founded | 2012 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.6M | 130.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CLNN | WEA |
|---|---|---|
| Price | $5.16 | $11.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $32.67 | N/A |
| AVG Volume (30 Days) | ★ 96.2K | 46.1K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.87% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $214,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $92.84 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.28 | $9.60 |
| 52 Week High | $13.50 | $11.29 |
Technical Indicators
Market Signals| Indicator | CLNN | WEA |
|---|---|---|
| Relative Strength Index (RSI) | 36.44 | 61.70 |
| Support Level | $4.50 | $11.11 |
| Resistance Level | $6.68 | $11.26 |
| Average True Range (ATR) | 0.61 | 0.08 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 31.06 | 84.37 |
Price Performance
Historical ComparisonAbout CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
About WEA Western Asset Bond Fund Share of Beneficial Interest
Western Asset Premier Bond Fund is a diversified closed-end management investment company. Its investment objective is to provide current income and capital appreciation by investing in a diversified portfolio of investment-grade bonds. The Fund invests in sectors, such as financials, energy, telecommunication services, consumer discretionary, healthcare, materials, information technology, and consumer staples.